9,334
Total Claims
$2.2M
Drug Cost
1,283
Beneficiaries
$1,699
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+11%
Cost per patient vs peers
$1,699 vs $1,524 avg
+32%
Brand preference vs peers
18.0% vs 13.7% avg
Brand vs Generic
82% generic
Brand: 1,684 claims · $2.0M
Generic: 7,650 claims · $166K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 739 | $887K |
| Sacubitril/Valsartan | 298 | $416K |
| Rivaroxaban | 167 | $192K |
| Dapagliflozin Propanediol | 123 | $141K |
| Evolocumab | 59 | $67K |
| Alirocumab | 44 | $56K |
| Dronedarone Hcl | 15 | $31K |
| Ranolazine | 105 | $20K |
| Metoprolol Succinate | 997 | $20K |
| Ticagrelor | 16 | $17K |
| Empagliflozin | 16 | $14K |
| Diltiazem Hcl | 246 | $8,427 |
| Isosorbide Mononitrate | 462 | $7,474 |
| Atorvastatin Calcium | 641 | $7,360 |
| Potassium Chloride | 305 | $7,215 |
Prescribing Profile
55
Unique Drugs
$1.6M
Patient Profile
75
Avg Age
48%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data